Search results

Institutional investors should implement and publicly report on a responsible investment policy that addresses poverty and development issues according to a new report by Oxfam launched today.

Big Pharma — long-blasted for gouging prices, avoiding taxes, and rigging the political process to maximize profits — has emerged as key players in the race to bring an end to the COVID-19 crisis. Who gets access to lifesaving medicines and vaccines — and when — will determine who lives and who dies.

European aid to poor countries is stalling two years ahead of the UN Millennium Development Goals deadline, with aid cut or stagnant in 19 member states, reveals the new Concord AidWatch report.

The G20, the preeminent global economic decision making body, has thrown its political weight behind the commitment to shared growth and narrowing the development gap through its Seoul Deve

The richest 1 percent grabbed nearly two-thirds of all new wealth worth $42 trillion created since 2020, almost twice as much money as the bottom 99 percent of the world’s population, reveals a new Oxfam report today. During the past decade, the richest 1 percent had captured around half of all new wealth. 

A year after WHO declared COVID-19 a global pandemic, the virus has laid bare the stark gender inequality that continues to shape our world. Despite being at the forefront of the response, women have borne the brunt of this crisis. On International Women's Day, we must reflect on why this happened and why it is absolutely critical for women and girls to have an equal voice and co-lead in rebuilding after COVID-19.

New Oxfam estimates show that 263 million more people could be pushed into extreme poverty in 2022, due to the combined impact of COVID-19, inequality and food and energy price inflation – accelerated by the war in Ukraine. Without urgent and bold national and international action, inequality and poverty will deepen, with poorer countries – many of which face looming debt crises – pushed deeper into poverty.

As the UN General Assembly kicks off again this year, Oxfam’s experts and partners are available to speak to their work focused on the People’s Vaccine for COVID-19, the climate crisis - including climate finance, and a number of pressing humanitarian crises. 

Welcoming the publication of the World Bank report, Turn Down the Heat: Climate Extremes, Regional Impa

New Oxfam research shows that four pharmaceutical corporations – Abbott, Johnson & Johnson, Merck & Co (MSD), and Pfizer – systematically hide their profits in overseas tax havens. This activity could deprive developing countries of more than $100 million every year – money that is urgently needed to meet the health needs of people in these countries.